Ye Wang
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.
Journal: Endocrine oncology (Bristol, England)
Published: December 09, 2025
Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trial.
Journal: Cancer causes & control : CCC
Published: March 10, 2025
Nonnutritive Sweetener Consumption, Metabolic Risk Factors, and Inflammatory Biomarkers Among Adults in the Cancer Prevention Study-3 Diet Assessment Sub-Study.
Journal: The Journal of nutrition
Published: February 06, 2025
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy.
Journal: Nature
Published: June 21, 2024
Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition.
Journal: BMC cancer
Published: May 05, 2023
Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization Study.
Journal: Diabetes care
Published: May 15, 2021
Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate Cancer.
Journal: JNCI cancer spectrum
Published: May 09, 2021
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.
Journal: Obesity (Silver Spring, Md.)
Published: March 28, 2017
Circulating resistin levels and risk of multiple myeloma in three prospective cohorts.
Journal: British journal of cancer
Published: January 31, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026